Network structure and the role of key players in a translational cancer research network: a study protocol
- Centre for Clinical Governance Research, University of New South Wales, Kensington, New South Wales, Australia
- Correspondence to Janet C Long;
- Received 7 May 2012
- Accepted 31 May 2012
- Published 25 June 2012
Introduction Translational research networks are a deliberate strategy to bridge the gulf between biomedical research and clinical practice through interdisciplinary collaboration, supportive funding and infrastructure. The social network approach examines how the structure of the network and players who hold important positions within it constrain or enable function. This information can be used to guide network management and optimise its operations. The aim of this study was to describe the structure of a translational cancer research network (TCRN) in Australia over its first year, identify the key players within the network and explore these players' opportunities and constraints in maximising important network collaborations.
Methods and analysis This study deploys a mixed-method longitudinal design using social network analysis augmented by interviews and review of TCRN documents. The study will use network documents and interviews with governing body members to explore the broader context into which the network is embedded as well as the perceptions and expectations of members. Of particular interest are the attitudes and perceptions of clinicians compared with those of researchers. A co-authorship network will be constructed of TCRN members using journal and citation databases to assess the success of past pre-network collaborations. Two whole network social network surveys will be administered 12 months apart and parameters such as density, clustering, centrality and betweenness centrality computed and compared using UCINET and Netdraw. Key players will be identified and interviewed to understand the specific activities, barriers and enablers they face in that role.
Ethics and dissemination Ethics approvals were obtained from the University of New South Wales, South Eastern Sydney Northern Sector Local Health Network and Calvary Health Care Sydney. Results will be discussed with members of the TCRN, submitted to relevant journals and presented as oral presentations to clinicians, researchers and policymakers.
To cite: Long JC, Cunningham FC, Braithwaite J. Network structure and the role of key players in a translational cancer research network: a study protocol. BMJ Open 2012;2:e001434. doi:10.1136/bmjopen-2012-001434
Contributors Protocol developed by all three authors. JCL wrote the paper, and FCC and JB critically reviewed all drafts and final copy.
Funding This work was supported by ARC Discovery Project (grant number DP0986493).
Competing interests None.
Ethics approval Ethics approval was provided by the University of New South Wales, appropriate local health network and site-specific committees.
Provenance and peer review Not commissioned; externally peer reviewed.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.